IgA nephropathy
Conditions
Interventions
experimental group:Hushen Yiqi Granule combined with basic treatment of western medicine
Sponsors
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Pathological diagnosis of patients with IgA nephropathy; 2. 24-hour urine protein quantitation >= 1.0g (two tests, interval > 7 days), or CKD 2-4; 3. Aged 18-80 years; 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combine life-threatening complications such as severe infections, new malignant tumors, severe water-electrolyte disorders, severe heart, brain, liver, hematopoietic system, and gastrointestinal tract such as vital organ diseases or dysfunctions; 2. Those who are known to be allergic to the drugs used; 3. Patients with mental illness; 4. Pregnant or lactating women; 5. Being accepted by other clinical trials; 6. Patients with secondary IgA nephropathy; 7. Patients with IgA nephropathy who present with progressive nephritis; 8. Other persons who have no capacity for civil conduct and limit their capacity for civil conduct.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ;Proteinuria increased by 50% from baseline ; | — |
Secondary
| Measure | Time frame |
|---|---|
| New onset of cardiovascular events requiring hospitalization;New onset of infection requiring hospitalization;Patient enter the ESRD stage ; | — |
Countries
China
Contacts
Public ContactZhaohui Ni
Outcome results
None listed